Loading…
Teladoc Health, Inc. is projected to rise to $9.42 by 2027, a +40% move from its current price of $6.71. TDOC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $6.47 | $6.72 | $6.97 | +0.12% |
| Aug 3 | $6.38 | $6.73 | $7.09 | +0.24% |
| Aug 4 | $6.31 | $6.73 | $7.18 | +0.36% |
| Aug 5 | $6.26 | $6.74 | $7.26 | +0.49% |
| Aug 6 | $6.21 | $6.75 | $7.34 | +0.61% |
| Aug 7 | $6.17 | $6.76 | $7.41 | +0.73% |
| Aug 8 | $6.13 | $6.77 | $7.47 | +0.85% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.13 | $6.77 | $7.47 | +0.85% |
| Week 2 | $5.94 | $6.82 | $7.85 | +1.71% |
| Week 3 | $5.80 | $6.88 | $8.17 | +2.57% |
| Week 4 | $5.70 | $6.94 | $8.46 | +3.45% |
| Week 5 | $5.61 | $7.00 | $8.73 | +4.33% |
| Week 6 | $5.54 | $7.06 | $8.99 | +5.22% |
| Week 7 | $5.48 | $7.12 | $9.24 | +6.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments.
The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians.
The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc.
and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.
Teladoc Health, Inc. (TDOC) is a healthcare company. Its current price is $6.58, with a market capitalization of $1.2B and a rank of 2266 in market positioning.
The long-range forecast paints a bullish path, with a 2030 average price of $12.59 and a 2050 average price of $95.47, and a 2050 maximum of $202.67. The 2030 minimum is $8.70 and the 2030 maximum is $19.77, illustrating substantial upside versus today.
For 2026, the forecast shows a baseline of min $4.47, avg $6.58, max $10.20, with ROI at 0 and sentiment NEUTRAL; from 2027 onward, the trajectory strengthens, featuring rising averages and higher ROIs through 2031 and beyond, culminating in a strong bullish multiyear outlook.
A major floor 32.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.9% away) — a key level to hold.
The nearest ceiling, 44.9% above — a clean break opens room to run.
A major ceiling 61.1% above — clearing it would confirm fresh momentum.
Key TDOC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TDOC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.15 | Sell | $7.76 | Sell |
| MA 10 | $8.64 | Sell | $8.32 | Sell |
| MA 20 | $9.02 | Sell | $8.58 | Sell |
| MA 50 | $8.13 | Sell | $8.15 | Sell |
| MA 100 | $6.98 | Sell | $7.52 | Sell |
| MA 200 | $6.89 | Sell | $7.30 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.51 | Neutral |
| Stoch RSI (14) | 4.25 | Buy |
| CCI (20) | -276.84 | Sell |
| Williams %R (14) | -95.86 | Info |
| MACD (12,26,9) | -0.35 | Sell |
| ROC (12) | -30.97 | Sell |
| Bollinger %B (20,2) | -0.18 | Buy |
| Stochastic %K (14) | 4.14 | Buy |
| TRIX (15) | 0.44 | Buy |
| Awesome (5,34) | -0.48 | Sell |
| Ultimate (7,14,28) | 26.10 | Buy |
| Momentum (10) | -2.72 | Sell |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 7.46 | Sell |
| ADX (14) | 24.75 | Sell |
| ATR (14) | 0.40 | Info |
The 30-day technical picture is neutral in sentiment. RSI(14) sits at 30, indicating an evenly balanced momentum near the oversold threshold. The SMA50 is listed at $8.13 and the SMA200 at $6.90, with a defined support at $6.58 and a resistance at $9.72.
The 30-day range spans from a low of $5.11 to a high of $8.47, highlighting limited upside within the near term. Annualized volatility is high at 70%, underscoring notable price swings even within a short horizon.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.47 | $6.71 | $10.33 | 0% | Neutral | |
| $7.26 | $9.42 | $13.06 | +40% | Bullish | |
| $7.33 | $9.89 | $14.40 | +47% | Bullish | |
| $8.87 | $12.39 | $18.72 | +85% | Bullish | |
| $8.93 | $12.85 | $20.04 | +91% | Bullish | |
| $9.18 | $13.57 | $21.74 | +102% | Bullish | |
| $12.05 | $18.28 | $30.00 | +172% | Bullish | |
| $14.20 | $22.06 | $37.01 | +229% | Bullish | |
| $16.41 | $26.10 | $44.67 | +289% | Bullish | |
| $17.45 | $28.38 | $49.48 | +323% | Bullish | |
| $25.75 | $46.46 | $87.43 | +592% | Bullish | |
| $44.27 | $96.43 | $202.41 | +13.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.47 | $6.71 | $8.71 | +0.00% |
| September 2026 | $6.27 | $7.50 | $9.28 | +11.76% |
| October 2026 | $6.21 | $7.49 | $9.41 | -0.08% |
| November 2026 | $6.32 | $7.69 | $9.76 | +2.59% |
| December 2026 | $6.57 | $8.05 | $10.33 | +4.77% |
Click any year to see its month-by-month TDOC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Teladoc Health, Inc.'s 2026 outlook centres on $6.71, within a $4.47 to $10.33 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, TDOC could reach as high as $13.06, with a base case around $9.42 and support toward $7.26 — roughly +40% from $6.71. Momentum favours further upside here.
Expect TDOC to range from $7.33 to $14.40 through 2028. The $9.89 average target implies a +47% move from current prices. That is up +5% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The TDOC price prediction for 2029 points to an average of $12.39 (low $8.87, high $18.72) — a potential gain of +85% on today's $6.71. Momentum favours further upside here.
In 2030, TDOC is projected to trade between $8.93 and $20.04, averaging $12.85 — a potential gain of +91% from today's $6.71. That is up +4% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Teladoc Health, Inc.'s 2031 outlook centres on $13.57, within a $9.18 to $21.74 range. That is up +6% on the projected 2030 average. That marks a +102% change versus current levels. Momentum favours further upside here.
By 2032, TDOC could reach as high as $30.00, with a base case around $18.28 and support toward $12.05 — roughly +172% from $6.71. Buyers look set to stay in control over this stretch.
Expect TDOC to range from $14.20 to $37.01 through 2033. The $22.06 average target implies a +229% move from current prices. That is up +21% on the projected 2032 average. Momentum favours further upside here.
The TDOC price prediction for 2034 points to an average of $26.10 (low $16.41, high $44.67) — a potential gain of +289% on today's $6.71. Buyers look set to stay in control over this stretch.
In 2035, TDOC is projected to trade between $17.45 and $49.48, averaging $28.38 — a potential gain of +323% from today's $6.71. That is up +9% on the projected 2034 average. Momentum favours further upside here.
Teladoc Health, Inc.'s 2040 outlook centres on $46.46, within a $25.75 to $87.43 range. That is up +64% on the projected 2035 average. That marks a +592% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, TDOC could reach as high as $202.41, with a base case around $96.43 and support toward $44.27 — roughly +13.4x from $6.71. Momentum favours further upside here.
Investing $1,000 in TDOC today (≈ 149.031297 TDOC) could be worth
$14,370.57
+$13,370.57 (+1337%) by 2050 · US Dollar
Based on the average projected TDOC price of $96.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TDOCwould be worth at today's price.
$1,000 invested in TDOC on Jul 31, 2025 (≈ 138.696254 TDOC) would be worth
$930.65
-$69.35 (-6.9%) today · 0.93× · US Dollar
Based on a TDOC entry price of $7.21 vs. today's $6.71.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.77 | $765.11 | -23.5% |
| 1 month ago | $9.1 | $737.36 | -26.3% |
| 3 months ago | $6.46 | $1,038.7 | +3.9% |
| 6 months ago | $5.37 | $1,249.53 | +25.0% |
| 1 year ago | $7.21 | $930.65 | -6.9% |
| All time (5.0y) ago | $150.06 | $44.72 | -95.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TDOC forecast.
Our base-case forecast reaches $13.00 around 2031.
Implied market cap at $13.00: $2.36B
The multi-year forecast describes a bullish trajectory beyond the near term. By 2026 the min is $4.47, the avg is $6.58, and the max is $10.20, with ROI at 0 and sentiment NEUTRAL.
From 2027 onward, the forecast shows a continuing upside with 2027 avg $9.25, 2028 avg $9.71, and 2029 avg $12.19, with ROIs of 40.6%, 47.6%, and 85.3% respectively, and sentiment BULLISH. By 2030, the avg is $12.59 (min $8.70, max $19.77) with ROI 91.4% and sentiment BULLISH.
Into the 2040s and beyond, the forecast remains strongly bullish, with 2040 avg $46.09 (min $25.18, max $87.58) and ROI 600.5%, followed by 2050 avg $95.47 (min $42.96, max $202.67) and ROI 1350.9%.
These are projections and not guarantees; actual results may vary with market conditions and other factors.
Tap a question to reveal the answer.
2030 avg $12.59 with min $8.70 and max $19.77; ROI 91.4%; sentiment BULLISH.
Forecasts show bullish sentiment in 2027-2050, with 2027 avg $9.25, 2028 avg $9.71, 2029 avg $12.19, 2030 avg $12.59, 2040 avg $46.09, and 2050 avg $95.47; ROIs range from 40.6% to 1350.9%. These are estimates, not guarantees.
Yes. The 2050 max is $202.67, and the 2050 avg is $95.47, indicating potential to surpass $100 on the high end of the forecast.
Sentiment is NEUTRAL with RSI(14) at 30. SMA50 is $8.13, SMA200 is $6.90. Support is $6.58 and resistance is $9.72. The 30-day range is $5.11 to $8.47, and annualized volatility is 70%.
Current price is $6.58 and market cap is $1.2B; the rank is 2266 in market positioning.
Teladoc Health, Inc. Community Discussion
0Share your Teladoc Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.